{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:52:24Z","timestamp":1782917544388,"version":"3.54.5"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Although the overall prognosis of most thyroid cancers is relatively good, the benefits of immunotherapy in advanced, dedifferentiated, and some special subtypes still show significant heterogeneity. The existing evaluation frameworks based on PD-L1, tumor mutational burden, or conventional transcriptomic signals are insufficient to explain the complex and variable immune response patterns among different patients and within the same tumor. In recent years, single-cell sequencing, spatial transcriptomics, and related spatial multi-omics studies have shown that the immune microenvironment of thyroid cancer is not a homogeneous background but is composed of multiple local ecological niches with clear spatial organizational characteristics. These ecological niches have significant differences in cell composition, functional state, and interaction mode. The current evidence suggests that the regions rich in B cells and tertiary lymphoid structures in papillary thyroid carcinoma are often associated with relatively indolent clinical behaviors; undifferentiated thyroid carcinoma more frequently presents as an inhibitory spatial pattern characterized by macrophages, cancer-associated fibroblasts, and immune exclusion boundaries; and the neural-immune crosstalk in medullary thyroid carcinoma further indicates that some \u201ccold\u201d immune phenotypes may be actively shaped by neuroendocrine signals. From the perspective of spatial immune niches, this article re-examines the biological basis and translational significance of hot, cold, and excluded immune patterns in thyroid cancer, and discusses their potential implications for immune classification, biopsy strategies, and the optimization of precise immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1863184","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:08:40Z","timestamp":1782914920000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatially resolved immune niches in thyroid cancer: from hot\u2013cold\u2013excluded ecosystems to precision immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Guizhang","family":"Hou","sequence":"first","affiliation":[{"name":"The First Clinical College, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34657","article-title":"Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 keynote-158 study","volume":"129","author":"Oh","year":"2023","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.4729","article-title":"Anti-programmed death ligand 1 plus targeted therapy in anaplastic thyroid carcinoma: a nonrandomized clinical trial","volume":"10","author":"Cabanillas","year":"2024","journal-title":"JAMA Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf3657","article-title":"Characterizing dedifferentiation of thyroid cancer by integrated analysis","volume":"7","author":"Luo","year":"2021","journal-title":"Sci Adv"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506925","article-title":"Spatial transcriptomics reveals transcriptomic and immune microenvironment reprogramming during thyroid carcinoma dedifferentiation","volume":"12","author":"Ning","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13046-025-03341-7","article-title":"Single-cell transcriptomics analysis reveals that the tumor-infiltrating b cells determine the indolent fate of papillary thyroid carcinoma","volume":"44","author":"Li","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1038\/s41467-024-49824-7","article-title":"The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer","volume":"15","author":"Hou","year":"2024","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00262-025-04210-0","article-title":"Tumor microenvironment remodeling across thyroid cancer differentiation states revealed by spatial transcriptomics","volume":"74","author":"Seok","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1594","article-title":"Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment","volume":"14","author":"Yan","year":"2024","journal-title":"Clin Transl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1089\/thy.2024.0072","article-title":"Characterization of immune infiltrate along the leading edge of differentiated thyroid cancer","volume":"34","author":"Kotwal","year":"2024","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.09.001","article-title":"Spatial oncology: translating contextual biology to the clinic","volume":"42","author":"Gong","year":"2024","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02072-w","article-title":"B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer","volume":"46","author":"Li","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-1047","article-title":"CD36+ proinflammatory macrophages interact with ZCCHC12+ tumor cells in papillary thyroid cancer promoting tumor progression and recurrence","volume":"12","author":"Zhang","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169653","article-title":"Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics","volume":"133","author":"Lu","year":"2023","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173712","article-title":"A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer","volume":"9","author":"Han","year":"2024","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112102","article-title":"Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer","volume":"133","author":"Bao","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0427","article-title":"Macrophage-induced carboxypeptidase a4 promotes the progression of anaplastic thyroid cancer","volume":"34","author":"Choi","year":"2024","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132296","article-title":"Medullary thyroid cancer: molecular drivers and immune cellular milieu of the tumour microenvironment-implications for systemic treatment","volume":"16","author":"Papachristos","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41421-022-00479-y","article-title":"Integrated proteogenomic characterization of medullary thyroid carcinoma","volume":"8","author":"Shi","year":"2022","journal-title":"Cell Discov"},{"key":"B22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00831-w","article-title":"Neuro-immune cross-talk in cancer","volume":"25","author":"Amit","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells14120936","article-title":"Spatial transcriptomics in thyroid cancer: applications, limitations, and future perspectives","volume":"14","author":"Song","year":"2025","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17050794","article-title":"Thyroid cancer-the tumor immune microenvironment (time) over time and space","volume":"17","author":"Jaume","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 american thyroid association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0312","article-title":"Immune profiling of advanced thyroid cancers using fluorescent multiplex immunohistochemistry","volume":"31","author":"Ahn","year":"2021","journal-title":"Thyroid"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-1165","article-title":"Highly multiplexed tissue imaging in precision oncology and translational cancer research","volume":"14","author":"Bollhagen","year":"2024","journal-title":"Cancer Discov"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04383-9","article-title":"Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules","volume":"90","author":"Capitoli","year":"2025","journal-title":"Endocrine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1863184\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:08:41Z","timestamp":1782914921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1863184\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2026.1863184"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1863184","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1863184"}}